Myomo Inc (MYO) Noticias

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock

Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from...

Form 424B5 - Prospectus [Rule 424(b)(5)]

Myomo, Inc. Announces Proposed Public Offering of Common Stock

Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Myomo Reports Record Third Quarter Financial and Operating Results

$9.2 million in revenue, raises full-year revenue guidance 225 MyoPro® authorizations and orders with 316 patients in backlog at quarter end 645...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage

Blue Cross Blue Shield of Massachusetts and Paradigm together serve 3 million covered lives Myomo, Inc. (NYSE American: MYO) (“Myomo” or the...

Myomo to Report Third Quarter Financial Results on November 6, 2024

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those...

Form 4 - Statement of changes in beneficial ownership of securities